Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
99
Views
5
CrossRef citations to date
0
Altmetric
Original Research

A real-life experience of sorafenib treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis at Cathay General Hospital, 2007–2015

Chi-Chun Huang1 Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan, [email protected]
,
Hsin-Yi Chen1 Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan, [email protected]
,
Ruei-Hsin Chang1 Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan, [email protected]
,
Pen-An Liao2 Department of Radiology, Cathay General Hospital Medical Center, Taipei, Taiwan
,
Heng-Hui Lien3 School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan, [email protected];4 Department of Surgery, Cathay General Hospital Medical Center, Taipei, Taiwan
,
Chih-Sheng Hung5 Department of Gastroenterology, Cathay General Hospital Medical Center, Taipei, Taiwan
,
Sien-Sing Yang1 Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan, [email protected];3 School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan, [email protected]
&
Jui-Ting Hu1 Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan, [email protected];3 School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan, [email protected]Correspondence[email protected]
 show all
Pages 397-404 | Published online: 22 Jan 2019

References

  • GohGBChangPETanCKChanging epidemiology of hepatocellular carcinoma in AsiaBest Pract Res Clin Gastroenterol201529691992826651253
  • BarazaniYHiattJRTongMJBusuttilRWChronic viral hepatitis and hepatocellular carcinomaWorld J Surg20073161243124817440771
  • SaccoRTapeteGSimonettiNTransarterial chemoembolization for the treatment of hepatocellular carcinoma: a reviewJ Hepatocell Carcinoma2017410511028795053
  • FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
  • HuynhHOngRWLiPYTargeting receptor tyrosine kinase pathways in hepatocellular carcinomaAnticancer Agents Med Chem201111656057521554207
  • CervelloMBachvarovDLampiasiNMolecular mechanisms of sorafenib action in liver cancer cellsCell Cycle201211152843285522801548
  • WörnsMAGallePRSorafenib for the treatment of hepatocellular carcinomaHepat Oncol20141218920430190954
  • RimassaLSantoroASorafenib therapy in advanced hepatocellular carcinoma: the SHARP trialExpert Rev Anticancer Ther20099673974519496710
  • ChengALKangYKChenZEfficacy and safety of Sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253419095497
  • GantenTMStauberRESchottESorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT StudyClin Cancer Res201723195720572828698202
  • IavaroneMCabibboGPiscagliaFSOFIA (SOraFenib Italian Assessment) study groupField-practice study of Sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in ItalyHepatology20115462055206321898496
  • LencioniRKudoMYeSLFirst interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with SorafeNib) non-interventional studyInt J Clin Pract201266767568322698419
  • LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
  • PeixotoRDRenoufDJGillSCheungWYLimHJRelationship of ethnicity and overall survival in patients treated with Sorafenib for advanced hepatocellular carcinomaJ Gastrointest Oncol20145425926425083298
  • Al-RajabiRPatelSKetchumNSComparative dosing and efficacy of Sorafenib in hepatocellular cancer patients with varying liver dysfunctionJ Gastrointest Oncol20156325926726029452
  • SchmidtTMLiuLIAbrahamIEUyABDudekAZEfficacy and safety of Sorafenib in a racially diverse patient population with advanced hepatocellular carcinomaAnticancer Res20183874027403429970527
  • LlovetJMBrúCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis199919332933810518312
  • A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigatorsHepatology19982837517559731568
  • SinnDHChoJYGwakGYDifferent survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spreadPLoS One2015104e012443425923439
  • WadaYTakamiYMatsushimaHThe safety and efficacy of combination therapy of Sorafenib and radiotherapy for advanced hepatocellular carcinoma: a retrospective studyIntern Med201857101345135329279513
  • HuHDuanZLongXSorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching studyPLoS One201495e9662024817002
  • ChoiGHShimJHKimMJSorafenib alone versus Sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analysesRadiology2013269260361123864102

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.